NCT01044498 A Study of Tocilizumab in Combination With an Oral Contraceptive in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01041248 Single Patient Study to Treat Relapsing Polychondritis With Tocilizumab Status COMPLETED Phase NA
NCT01007435 A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00996606 A Study of Tocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDs Status COMPLETED Phase PHASE3
NCT00988221 A Study of Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic Arthritis Status COMPLETED Phase PHASE3
NCT00868751 Single Patient Use of Tocilizumab in Systemic Onset Juvenile Idiopathic Arthritis Status TERMINATED Phase NA
NCT00862758 Request for Single Patient IND for Compassionate/Emergency Use of Tocilizumab Status NO_LONGER_AVAILABLE Phase N/A
NCT00754559 A Study to Assess Efficacy With Respect to Clinical Improvement in Disease Activity and Safety of Tocilizumab in Patients Wtih Active Rheumatoid Arthritis. Status COMPLETED Phase PHASE3
NCT00721123 A Long-term Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00720798 An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies Status COMPLETED Phase PHASE3
NCT00535782 A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00531817 A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis Status COMPLETED Phase PHASE3